FDA Approved: ZYPREXA INTRAMUSCULAR — Supplemental Application (Eli Lilly and Company)

View source ↗

Summary

The FDA approved a supplemental application for ZYPREXA INTRAMUSCULAR (olanzapine) by Eli Lilly and Company. The action results in changes to the product labeli…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Schizophrenia

Drugs mentioned

• ZYPREXA INTRAMUSCULAR (olanzapine)

Snippet

SUPPL AP for ZYPREXA INTRAMUSCULAR (OLANZAPINE)